Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Outer membrane vesicles derived from gut microbiota mediate tubulointerstitial inflammation: a potential new mechanism for diabetic kidney disease
Pei Pei Chen, Jia Xiu Zhang, Xue Qi Li, et al.
Theranostics (2023) Vol. 13, Iss. 12, pp. 3988-4003
Open Access | Times Cited: 22

Showing 22 citing articles:

New insights in the treatment of DKD: recent advances and future prospects
Meimei Zhao, Yongtong Cao, Liang Ma
BMC Nephrology (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Gut–X axis
Lin Xu, Yu Zhang, Xueyan Li, et al.
iMeta (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Understanding How Pre- and Probiotics Affect the Gut Microbiome and Metabolic Health
Patrícia Martins Bock, Andreza Francisco Martins, Beatriz D. Schaan
AJP Endocrinology and Metabolism (2024) Vol. 327, Iss. 1, pp. E89-E102
Closed Access | Times Cited: 6
Molecular mechanisms of gut microbiota in diabetic nephropathy
Gang Cheng, Yulin Liu, Rong Guo, et al.
Diabetes Research and Clinical Practice (2024) Vol. 213, pp. 111726-111726
Closed Access | Times Cited: 6
Kidney tea [Orthosiphon aristatus (Blume) Miq.] improves diabetic nephropathy via regulating gut microbiota and ferroptosis
Zheng Zhou, Hongjuan Niu, Meng Bian, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Effects of bacterial extracellular vesicles derived from oral and gastrointestinal pathogens on systemic diseases
Han Zhang, Y. Lin, Siwei Li, et al.
Microbiological Research (2024) Vol. 285, pp. 127788-127788
Closed Access | Times Cited: 5
Gut microbiota, a key to understanding the knowledge gaps on micro-nanoplastics-related biological effects and biodegradation
Jiping Wang, Yutong Wang, Zhenyu Li, et al.
The Science of The Total Environment (2024) Vol. 944, pp. 173799-173799
Closed Access | Times Cited: 5
Lactic acid bacteria derived extracellular vesicles: emerging bioactive nanoparticles in modulating host health
Mohan Li, Bingyong Mao, Xin Tang, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Frontier role of extracellular vesicles in kidney disease
Bei Li, Qi Chen, Yifan Zhang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Bacterial extracellular vesicles for gut microbiome-host communication and drug development
Dingfei Qian, Panpan Xu, Xinwei Wang, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Morroniside alleviates cisplatin-induced renal injury and gut dysbiosis via the gut–kidney axis and ferroptosis
H Li, Ke Xu, Wenhao Mao, et al.
International Immunopharmacology (2025) Vol. 153, pp. 114430-114430
Closed Access
Gut Microbiota and Their Metabolites: The Hidden Driver of Diabetic Nephropathy? Unveiling Gut Microbe's Role in DN
J. Liu, Min Guo, Xiaobin Yuan, et al.
Journal of Diabetes (2025) Vol. 17, Iss. 4
Open Access
Bacterial extracellular vesicles in osteoarthritis: a new bridge of the gut-joint axis
Li‐na Niu, Wanzhuo Chen, Zhifeng Yin, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Iridoids modulate inflammation in diabetic kidney disease: A review
Tongyi Zhou, Na Tian, Liu Li, et al.
Journal of Integrative Medicine (2024) Vol. 22, Iss. 3, pp. 210-222
Closed Access | Times Cited: 3
Roles of bacterial extracellular vesicles in systemic diseases
Yanzhen Wang, Xinghong Luo, Xiaozhen Xiang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 8
Association between gut microbiota and diabetic microvascular complications: a two-sample Mendelian randomization study
Peipei Zhou, Zhenning Hao, Yu Chen, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Guild-level signature of gut microbiome for diabetic kidney disease
Shasha Tang, Guojun Wu, Yalei Liu, et al.
mBio (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 2
The Bromodomain and extra-terminal Protein Inhibitor Apabetalone ameliorates kidney injury in diabetes by regulating cholesterol accumulation and modulating the gut microbiota
Min Wang, Zhaohui Huang, Yonghong Zhu, et al.
Kidney International Reports (2024)
Open Access | Times Cited: 1
Research progress of gut microbiome and diabetic nephropathy
C. P. Chu, Tapas Ranjan Behera, Ying Huang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Causal Relationships Between Gut Microbiota, Metabolites, and Diabetic Nephropathy: Insights from a Two-Sample Mendelian Randomization Analysis
Xixi Song, Jingqiu Cui, Shiwei Li, et al.
International Journal of Nephrology and Renovascular Disease (2024) Vol. Volume 17, pp. 319-332
Open Access
Development of Liver Fibrosis Represented by the Fibrosis-4 Index Is a Specific Risk Factor for Tubular Injury in Individuals with Type 2 Diabetes
Tomoyo Hara, Takeshi Watanabe, Hiroki Yamagami, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1789-1789
Open Access
Dose Determination and Administration of Bacterial Extracellular Vesicles for In Vivo Preclinical Studies
Justin D. Lathia, Dionysios C. Watson
Methods in molecular biology (2024), pp. 219-237
Closed Access
Page 1

Scroll to top